Surgical pulmonary valve replacement demonstrated superior mid-term cost-effectiveness compared to transcatheter replacement in young adults with repaired tetralogy of Fallot.
Does surgical pulmonary valve replacement improve mid-term cost-effectiveness compared to transcatheter pulmonary valve replacement in young adults with repaired tetralogy of Fallot and pulmonary valve regurgitation?
Clinical decision modeling suggests surgical pulmonary valve replacement is more cost-effective in the mid-term than transcatheter replacement for young adults with repaired tetralogy of Fallot.
Absolute Event Rate: 0% vs 0%
Comprehensive modelling of diverse outcomes showed that surgical pulmonary valve replacement had superior mid-term cost-effectiveness outcomes compared to transcatheter pulmonary valve replacement for young adults with repaired tetralogy of Fallot and pulmonary valve regurgitation. Sensitivity analysis found that the prevalence of post-transcatheter pulmonary valve replacement endocarditis and post-transcatheter pulmonary valve replacement surgical reintervention were influential outcomes for centres to consider when choosing between these strategies.
Zhu et al. (Sun,) reported a other. Surgical pulmonary valve replacement demonstrated superior mid-term cost-effectiveness compared to transcatheter replacement in young adults with repaired tetralogy of Fallot.